首页> 外文期刊>Oncology letters >Pylorus-preserving pancreaticoduodenectomy versus standard pancreaticoduodenectomy in the treatment of duodenal papilla carcinoma
【24h】

Pylorus-preserving pancreaticoduodenectomy versus standard pancreaticoduodenectomy in the treatment of duodenal papilla carcinoma

机译:Pylorus保存的胰腺癌切除术与标准胰蛋白酶切除术治疗十二指肠乳头癌

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

It is not known whether pylorus-preserving pancreaticoduodenectomy (PPPD) is as effective as the standard pancreaticoduodenectomy (SPD) in the treatment of duodenal papilla carcinoma (DPC). A retrospective cohort trial was undertaken to compare the results of these two procedures. Clinical data, histological findings, short-term results, survival and quality of life of all patients who had undergone surgery for primary DPC between January 2003 and February 2010 were analyzed. According to the inclusion criteria and the surgical methods, 116 patients were divided into the PPPD group (n = 43) and the SPD group (n = 73). There were no significant differences in various indices, including surgery duration, extent of intraoperative hemorrhage and postoperative pathological indexes. The incidence of postoperative complications, including pancreatic fistula and delayed gastric emptying, were also similar between the two groups (20.9 vs. 21.9%; P = 0.900 and 11.6 vs. 5.4%; P = 0.402). Long-term survival and quality of life were identical following a median follow-up of 45.6 months (range, 4-144 months). Within 6 months, there was a decreased loss of appetite following the pylorus-preserving procedure (26.9 vs. 49.3; P = 0.003). The procedures were equally effective for the treatment of DPC. PPPD offers minor advantages in the early postoperative period but not in the long term.
机译:不知道幽门保存胰腺癌胶质切除术(PPPD)是否与治疗十二指肠乳头癌(DPC)的标准胰蛋白酶切除术(SPD)有效。进行了回顾性队列试验,以比较这两个程序的结果。分析了2003年1月至2010年1月至2010年2月在2010年1月至2010年2月在2010年1月至2010年2月之间接受过初级DPC手术的临床资料,组织学结果,短期结果,生存和生活质量。根据含有标准和手术方法,将116名患者分成PPPD组(N = 43)和SPD组(n = 73)。各种指标没有显着差异,包括手术持续时间,术中出血程度和术后病理指标。术后并发症的发生率,包括胰腺瘘和延迟胃排空,两组之间也相似(20.9与21.9%; p = 0.900和11.6与5.4%; p = 0.402)。长期存活率和生活质量在中位随访45.6个月(范围,4-144个月)后相同。在6个月内,幽门保护程序后的食欲损失下降(26.9与49.3; p = 0.003)。该程序对DPC的治疗同样有效。 PPPD在术后早期的时间内提供了较小的优势,但在长期以来不会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号